MRC1 and central nervous system cancer: It was demonstrated that high levels of M2-type macrophages (marked as CD204 or CD206) (Ding et al., 2014), neutrophils (Liang et al., 2014), Tregs (Iwata et al., 2019) were defined as the adverse prognostic factors in glioma.